First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid
Journal
British Journal of Dermatology
Journal Volume
173
Journal Issue
1
Pages
302
Date Issued
2015-07
Author(s)
SDGs
Other Subjects
autoantibody; prednisolone; rituximab; corticosteroid; dermatological agent; rituximab; adult; aged; bullous pemphigoid; case control study; clinical article; comorbidity; controlled study; disease severity; eosinophil count; female; follow up; human; immunofluorescence; infection risk; Letter; male; patient referral; pneumonia; priority journal; remission; retrospective study; systemic therapy; treatment duration; urinary tract infection; drug combination; middle aged; Pemphigoid, Bullous; remission; treatment outcome; very elderly; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Case-Control Studies; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pemphigoid, Bullous; Remission Induction; Retrospective Studies; Rituximab; Treatment Outcome
Publisher
Blackwell Publishing Ltd
Type
letter